|Articles|March 13, 2020
UHPLC Analysis of mAbs
Author(s)YMC Europe GmbH
This note using YMC-Triart Bio C4 shows a robust separation at high temperatures for three commercially available mAbs: ofatumumab, palivizumab, and panitumumab.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
Green Stabilizers in Nitrocellulose Propellants: VOC Fingerprinting of Accelerated Aging by HS-SPME–GC×GC–TOF-MS
2
Translating Scientific Skills Into Impact: Careers Beyond Research and Academia
3
Reactivating Your GPC/SEC Instrument After Shutdown
4
The Scientist’s Value in the Age of Automation
5
